VistaGen Therapeutics, Inc. Financial Ratios — VTGN Stock

Profitability (USD)

	2010 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-502.01	-7,102.68	-2,107.22	-518.29	-5,206.52	-7,498.29	-436.22	-191.4	-194.46	-210.01	-31.45	-52.22	-123.78	-40.57	-49.44
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	100	100	- -	- -	- -	100	- -	- -	- -	100	100	100	100	100
EBITDA Margin (%)	- -	-622.62	-3,372.9	- -	- -	- -	-781.34	- -	- -	- -	-1,602.26	-4,223.63	25,874.89	-3,050.09	-11,386.42
Operating Margin (%)	- -	-626.02	-3,389.77	- -	- -	- -	-785.74	- -	- -	- -	-1,646.09	-4,287.75	26,109.25	-3,103.48	-11,517.08
Incremental Operating Margin (%)	- -	- -	- -	-982.78	- -	- -	- -	326.78	- -	- -	- -	- -	877.39	- -	- -
Pretax Margin (%)	- -	-909.54	-6,428.64	- -	- -	- -	-820.25	- -	- -	- -	-1,645.86	-4,306.88	26,097.8	-2,759.21	-10,578.4
Profit Margin (%)	- -	-909.66	-6,430.49	- -	- -	- -	-820.44	- -	- -	- -	-1,646.09	-4,307.19	26,100.44	-2,759.59	-10,579.84
Net Income to Common Margin (%)	- -	-909.66	-11,516.92	- -	- -	- -	-929.89	- -	- -	- -	-3,884.33	-4,392.42	26,100.44	-2,759.59	-10,579.84
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	44.16	- -	- -	8.17	11.77	6.7	4.43	5.73	57.62	1.94	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2010 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	- -	4	5	7	14	- -	- -	- -	- -	4	4	3	3	2	2
ST Debt	- -	1	1	2	14	- -	- -	- -	- -	- -	- -	- -	1	1	1
LT Debt	- -	3	5	5	- -	- -	- -	- -	- -	4	3	3	2	2	1
Total Debt/EBITDA	-0.06	-0.43	-0.79	-1.45	-2.12	-0.01	-0.01	- -	- -	-0.21	-0.21	-0.06	-0.05	-0.07	-0.03
Net Debt/EBITDA	0.15	-0.41	-0.69	-1.45	-2.11	0.03	0.29	0.75	0.53	0.07	5.91	1.45	0.28	3.67	1.21
Total Debt/EBIT	-0.06	-0.42	-0.79	-1.43	-2.1	-0.01	-0.01	- -	- -	-0.2	-0.21	-0.06	-0.05	-0.06	-0.03
Net Debt/EBIT	0.14	-0.41	-0.69	-1.43	-2.09	0.03	0.29	0.74	0.53	0.07	5.75	1.43	0.28	3.61	1.2
EBITDA to Interest Expense	- -	-4.41	-6.73	-3.05	-1.46	-15.08	-1,953.36	- -	-3,054.91	-1,324.74	-1,342.82	- -	-2,553.74	- -	- -
EBITDA-CapEx/Interest Expense	- -	-4.43	-6.87	-3.06	-1.46	-15.11	-2,001.18	- -	-3,076.66	-1,324.74	-1,364	- -	-2,562.96	- -	- -
EBIT to Interest Expense	- -	-4.44	-6.77	-3.09	-1.47	-15.14	-1,964.34	- -	-3,066.31	-1,331.61	-1,379.55	- -	-2,576.87	- -	- -
Interest Expense	- -	2	1	2	5	1	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-2,353.91	-16,031.56	2.67	-26,786.35	-31,338.9	-13,309.82	-3,824.95	-1,387.8	-1,292.42	-3,497.01	-202.86	-358.5	-1,549.84	-288.05	-483.28
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	1.93	0.13	0.09	- -	3.64	4.03	17.55	1.37	1.35
Long-Term Debt/Capital (%)	- -	-5.48	86.19	-7.51	-0.47	-0.02	-0.01	-0.01	- -	-1.88	-1.55	-0.98	-0.65	-0.44	-0.23
Long-Term Debt/Total Assets (%)	- -	821.93	525.2	1,815.17	123.43	2.75	0.32	0.08	0.04	64.42	3.09	3.49	10.05	1.27	1.12
Total Debt/Equity (%)	-53	-62.55	-42.59	-54.06	-69.43	-2.42	11.22	0.95	0.94	-71.42	4.04	4.7	22.44	1.85	2.14
Total Debt/Capital (%)	-1.03	-6.97	99.55	-10.86	-20.3	-0.05	-0.05	-0.04	-0.04	-2.07	-1.72	-1.15	-0.84	-0.6	-0.37
Total Debt/Total Assets (%)	24.09	1,044.76	606.63	2,623.89	5,288.62	7.26	1.86	0.58	0.48	70.89	3.43	4.07	12.86	1.71	1.79
Net Debt to Equity	127.8	-60.78	-37.4	-54.01	-69.08	12.01	-465.49	-149.27	-184.35	22.67	-112.1	-105.28	-136.86	-104.27	-95.37
Net Debt/Capital (%)	2.41	-6.76	99.2	-10.85	-20.18	0.27	1.98	6.19	6.72	0.65	32.32	20.48	4.85	25.18	14.19
EBITDA	- -	-8	-7	-5	-7	-12	-10	-14	-24	-20	-17	-47	-59	-32	-55
EBITDA-CapEx	- -	-8	-7	-5	-7	-12	-10	-14	-25	-20	-18	-47	-59	-33	-56
Operating Income (Loss)	- -	-8	-7	-5	-7	-12	-10	-14	-25	-20	-18	-48	-59	-33	-56

Liquidity (USD)

API Chat

	2010 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	0.56	0.03	0.26	- -	- -	0.24	2.14	7.12	4.68	0.49	24.61	11.82	3.64	23.26	6.38
Current Ratio	0.56	0.07	0.28	0.01	0.01	0.48	2.47	7.56	4.87	0.57	24.85	12.32	3.83	23.55	6.51
Quick Ratio	0.56	0.06	0.26	- -	- -	0.24	2.14	7.12	4.78	0.49	24.62	12.29	3.81	23.26	6.38
CFO/Avg Current Liab	-2.93	-2.24	-1.24	-0.56	-0.25	-0.5	-4.59	-6.41	-6.82	-5.66	-3.47	-9.09	-9.62	-5.32	-4.75
Common Equity/Total Assets	-2,353.91	-16,031.56	2.67	-26,786.35	-31,338.9	-13,309.82	-3,824.95	-1,387.8	-1,292.42	-3,497.01	-202.86	-358.5	-1,549.84	-288.05	-483.28
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	1.93	0.13	0.09	- -	3.64	4.03	17.55	1.37	1.35
Long-Term Debt/Capital (%)	- -	-5.48	86.19	-7.51	-0.47	-0.02	-0.01	-0.01	- -	-1.88	-1.55	-0.98	-0.65	-0.44	-0.23
Long-Term Debt/Total Assets (%)	- -	821.93	525.2	1,815.17	123.43	2.75	0.32	0.08	0.04	64.42	3.09	3.49	10.05	1.27	1.12
Total Debt/Equity (%)	-53	-62.55	-42.59	-54.06	-69.43	-2.42	11.22	0.95	0.94	-71.42	4.04	4.7	22.44	1.85	2.14
Total Debt/Capital (%)	-1.03	-6.97	99.55	-10.86	-20.3	-0.05	-0.05	-0.04	-0.04	-2.07	-1.72	-1.15	-0.84	-0.6	-0.37
Total Debt/Total Assets (%)	24.09	1,044.76	606.63	2,623.89	5,288.62	7.26	1.86	0.58	0.48	70.89	3.43	4.07	12.86	1.71	1.79
CFO/Total Liabilities	-214.94	-58.97	-25.77	-16.27	-13.3	-121.21	-234.53	-207.68	-209.44	-137	-74.06	-455.84	-551.85	-275.57	-301.75
CFO/CapEx	- -	-110.06	-25.58	-221.46	- -	-182.83	-30.37	-5,661.44	-83.49	- -	-43.84	-225.83	-234.51	-423.16	-220.4
Altman's Z-Score	-50.86	-308.1	-26.9	-458.42	-598.19	-224.37	-58.44	-20.71	-19.79	-59.63	4.48	8.78	-28.58	2.76	-4.64

Working Capital (USD)

API Chat

	2010 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2010 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	40	15	10	13	15	15	13	37	19	183	246	25	102	77
- Cash & Cash Equivalents	- -	- -	1	- -	- -	- -	3	10	13	1	103	68	17	119	67
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	4	5	7	14	- -	- -	- -	- -	4	4	3	3	2	2
Enterprise Value	- -	44	20	17	27	15	12	3	24	22	84	180	11	-15	-2
Total Capital	- -	-51	5	-64	-70	-132	-142	-156	-181	-198	-216	-265	-324	-354	-406
Total Debt/Capital (%)	-1.03	-6.97	99.55	-10.86	-20.3	-0.05	-0.05	-0.04	-0.04	-2.07	-1.72	-1.15	-0.84	-0.6	-0.37
Total Debt / EV	-0.41	0.08	0.27	0.41	0.52	- -	0.01	0.03	- -	0.19	0.04	0.02	0.24	-0.14	-0.85
EV/Sales	- -	32.68	98.5	- -	- -	- -	9.53	- -	- -	- -	77.17	162.7	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	14.81	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	14.81	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	40	15	10	13	15	15	13	37	19	183	246	25	102	77
Diluted Enterprise Value	- -	44	20	17	27	15	12	3	24	22	84	180	11	-15	12
EV per Share	- -	1,786.03	654.06	464.94	622.88	256.56	47.46	5.64	24.71	15.07	29.28	27.34	1.6	- -	- -
TTM Sales	- -	1	- -	- -	- -	- -	1	- -	- -	- -	1	1	- -	1	- -
TTM EBITDA	- -	-8	-7	-5	-7	-12	-10	-14	-24	-20	-17	-47	-59	-32	-55
TTM Operating Income	- -	-8	-7	-5	-7	-12	-10	-14	-25	-20	-18	-48	-59	-33	-56
TTM Cash Flow to Firm	- -	-2	-2	-1	2	-4	-7	-9	-15	-16	-12	-45	-50	-26	-42
TTM Free Cash Flow to Firm	- -	-2	-2	-1	2	-4	-7	-9	-14	-16	-12	-45	-49	-26	-42

Multiples (USD)

API Chat

	2010 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	-11.43	-4.52	-4.78	-4.76	-3.23	-2.1	-1.43	-2.55	-1.23	-15.55	-5.45	-0.51	-3.97	-1.84
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	44	20	17	27	15	12	3	24	22	84	180	11	-15	-2
Low Price	- -	1,050	36	150	94.8	120	52.2	20.7	24.3	8.7	10.5	31.8	2.4	1.62	2.22
EV/Sales	- -	32.68	98.5	- -	- -	- -	9.53	- -	- -	- -	77.17	162.7	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	-3.29	-0.8	-4.19	-0.99	-0.31	-2.57	-1.37	-1.6	-1.54	-2.13	-9.16	-1.59	-2.72	-2.01
Price/Earnings High	- -	-3.8	-2.2	-6.66	-1.42	-0.57	-5.83	-2.39	-2.71	-2.97	-6.47	-14.43	-6.31	-16.29	-3.45
Price/Earnings Low	- -	-2.11	-0.05	-1.85	-0.3	-0.14	-1.13	-0.62	-0.9	-0.58	-0.71	-4.31	-0.28	-1.07	-1.33
Price/Book Value	- -	-0.74	639.56	-0.14	-0.16	-0.12	-0.1	-0.08	-0.2	-0.1	-0.84	-0.92	-0.08	-0.29	-0.19
Price/Book Value Average	- -	-0.73	787.92	-0.18	-0.16	-0.12	-0.21	-0.13	-0.23	-0.17	-0.41	-1.67	-0.29	-0.22	-0.25
Price/Book Value High	- -	-0.85	2,157.55	-0.28	-0.23	-0.22	-0.48	-0.24	-0.38	-0.32	-1.25	-2.63	-1.14	-1.34	-0.43
Price/Book Value Low	- -	-0.47	46.23	-0.08	-0.05	-0.05	-0.09	-0.06	-0.13	-0.06	-0.14	-0.78	-0.05	-0.09	-0.17
Price/Tangible Book Value	- -	-7.08	-1.2	-0.79	-0.64	-5.18	24.13	1.87	5.17	-3.37	1.99	3.79	2.07	0.89	1.1
Price/Tangible Book Value Average	- -	-7.05	-1.47	-0.97	-0.67	-5.4	48.84	3.04	5.83	-5.9	0.98	6.89	7.78	0.7	1.47
Price/Tangible Book Value High	- -	-8.14	-4.04	-1.55	-0.96	-9.78	110.8	5.32	9.86	-11.4	2.98	10.86	30.94	4.18	2.52
Price/Tangible Book Value Low	- -	-4.52	-0.09	-0.43	-0.2	-2.37	21.42	1.39	3.27	-2.22	0.33	3.24	1.38	0.27	0.97
Price/Sales	- -	30.08	75	- -	- -	- -	11.81	- -	- -	- -	168.39	221.41	-110.37	96.04	158.83
Price/Sales Average	- -	29.96	92.4	- -	- -	- -	23.91	- -	- -	- -	82.55	402.22	-413.81	75.1	212.9
Price/Sales High	- -	34.59	253.01	- -	- -	- -	54.23	- -	- -	- -	251.4	633.87	-1,646.35	449.48	364.68
Price/Sales Low	- -	19.21	5.42	- -	- -	- -	10.48	- -	- -	- -	27.67	189.27	-73.58	29.47	141.04
Price/Cash Flow	- -	-11.32	-4.34	-4.75	-4.76	-3.22	-2.03	-1.43	-2.52	-1.23	-15.2	-5.43	-0.5	-3.96	-1.83
Price/Cash Flow Average	- -	-11.28	-5.35	-5.85	-4.94	-3.35	-4.11	-2.32	-2.84	-2.15	-7.45	-9.86	-1.89	-3.1	-2.46
Price/Cash Flow High	- -	-13.02	-14.64	-9.3	-7.14	-6.07	-9.33	-4.06	-4.8	-4.15	-22.69	-15.53	-7.52	-18.53	-4.21
Price/Cash Flow Low	- -	-7.23	-0.31	-2.58	-1.51	-1.47	-1.8	-1.06	-1.59	-0.81	-2.5	-4.64	-0.34	-1.21	-1.63
Price/Free Cash Flow Average	- -	-11.38	-5.56	-5.88	-4.94	-3.37	-4.26	-2.32	-2.87	-2.15	-7.62	-9.9	-1.9	-3.1	-2.47
Price/Free Cash Flow High	- -	-13.14	-15.24	-9.35	-7.14	-6.1	-9.65	-4.06	-4.86	-4.15	-23.22	-15.6	-7.55	-18.57	-4.23
Price/Free Cash Flow Low	- -	-7.3	-0.33	-2.6	-1.51	-1.48	-1.87	-1.06	-1.61	-0.81	-2.56	-4.66	-0.34	-1.22	-1.64
EV/Sales Average	- -	32.56	115.9	- -	- -	- -	21.63	- -	- -	- -	- -	343.52	- -	- -	77.88
EV/Sales High	- -	37.18	276.51	- -	- -	- -	51.95	- -	- -	- -	160.18	575.16	- -	339.48	229.65
EV/Sales Low	- -	21.81	28.92	- -	- -	- -	8.21	- -	- -	- -	- -	130.56	- -	- -	6.02
EV/EBITDA Average	0.15	-5.23	-3.44	-4.06	-4.15	-1.35	-2.77	-0.78	-1.15	-1.84	0.54	-8.13	-1.36	1.14	-0.68
EV/EBITDA High	0.15	-5.97	-8.2	-5.6	-5.06	-2.46	-6.65	-1.92	-2.32	-3.43	-10	-13.62	-6.13	-11.13	-2.02
EV/EBITDA Low	0.15	-3.5	-0.86	-2.6	-2.73	-0.57	-1.05	0.05	-0.41	-0.78	3.97	-3.09	-0.05	2.64	-0.05
EV/EBIT Average	0.14	-5.2	-3.42	-4.01	-4.11	-1.34	-2.75	-0.77	-1.15	-1.83	0.53	-8.01	-1.35	1.12	-0.68
EV/EBIT High	0.14	-5.94	-8.16	-5.53	-5.01	-2.45	-6.61	-1.91	-2.31	-3.41	-9.73	-13.41	-6.07	-10.94	-1.99
EV/EBIT Low	0.14	-3.48	-0.85	-2.57	-2.71	-0.57	-1.04	0.05	-0.41	-0.77	3.86	-3.05	-0.05	2.6	-0.05
Last Price	- -	1,644	498	276	300	262.5	58.8	27.9	38.4	13.2	63.9	37.2	3.6	5.28	2.5
High Price	- -	1,890	1,680	540	450	495	270	79.5	73.2	44.7	95.4	106.5	53.7	24.71	5.74
Enterprise Value Average	- -	44	23	19	28	16	27	11	28	37	-9	381	80	-37	38
Enterprise Value High	- -	50	55	27	34	29	65	27	57	68	175	638	360	361	112
Enterprise Value Low	- -	29	6	12	18	7	10	-1	10	15	-69	145	3	-86	3

	2010 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	- -	- -	- -	- -	- -	- -	- -	1	1	2	6	7	7	27	29
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	1	1	3	7	7	19	31
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	1	1	3	7	7	19	31
Revenue per Share	- -	54.65	6.64	- -	- -	- -	4.98	- -	- -	- -	0.38	0.17	-0.03	0.05	0.02
EBITDA per Share	-0.44	-340.25	-223.97	-130.22	-152.82	-198.78	-38.9	-29.86	-25.67	-13.59	-6.08	-7.1	-8.44	-1.68	-1.79
Operating Income per Share	-0.46	-342.1	-225.09	-131.71	-154.17	-199.68	-39.12	-30.04	-25.77	-13.66	-6.25	-7.2	-8.52	-1.71	-1.81
Basic EPS, GAAP	-0.46	-497.11	-764.74	-81.03	-315.87	-872.53	-46.3	-33.21	-27.02	-15.07	-14.74	-7.38	-8.51	-1.52	-1.67
Basic EPS from Cont Ops	-0.46	-497.11	-426.99	-81.03	-315.87	-801.28	-40.85	-30.98	-25.83	-14.21	-6.25	-7.24	-8.51	-1.52	-1.67
Diluted EPS, GAAP	-0.46	-497.11	-764.74	-81	-315.87	-872.53	-46.3	-33.21	-27.02	-15.07	-14.74	-7.38	-8.51	-1.52	-1.67
Diluted EPS from Cont Ops	-0.46	-497.11	-426.99	-81	-315.87	-801.28	-40.85	-30.98	-25.83	-14.21	-6.25	-7.24	-8.51	-1.52	-1.67
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.35	-145.18	-114.75	-58.05	-62.99	-81.6	-28.93	-19.56	-15.26	-10.78	-4.21	-6.86	-7.14	-1.33	-1.36
Free Cash Flow per Basic Share	-0.35	-146.5	-119.24	-58.31	-62.99	-82.04	-29.88	-19.57	-15.44	-10.78	-4.3	-6.89	-7.17	-1.34	-1.37
Cash & Equivalents per Share	0.09	3.3	21.14	- -	1.59	7.27	11.64	22.42	13.76	0.93	35.91	10.32	2.39	6.16	2.61
Book Value per Share	-2.66	-2,229.71	0.78	-1,928.67	-1,922.68	-2,235.51	-565.57	-338.06	-190.2	-138.04	-76.51	-40.55	-46.96	-18.4	-13.2
Tangible Book Value per Share	-0.05	-232.32	-416.07	-349.51	-467.32	-50.63	2.44	14.93	7.43	-3.92	32.03	9.81	1.74	5.9	2.28

VistaGen Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)